Skip to content

Efficacy assessment of cell therapy in skin aging

Efficacy assessment of adipose drive stem cell in nasolabial fold wrinkles

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014100719432N1
Enrollment
16
Registered
2015-05-31
Start date
2014-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrophic disorders of skin (aging). Atrophic disorder of skin, unspecified

Interventions

2cc suspension of adipose drive stem cell (SVF) that made from 100 cc abdominal adipose will injected in nasolabial fold and the end, healing rate of nasolabial fold wrinkle will measured..
2cc suspension of adipose drive stem cell (SVF) that made from 100 cc abdominal adipose will injected in nasolabial fold and the end, healing rate of nasolabial fold wrinkle will measured.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age about 35 to 55 years old; Having no anatomic disorder in face; Wrinkle type between grade 2 to 4; Normal mental health; Having a good cooperation with research team; Exclusion criteria: being smokers or drinkers; any past skin intervention in face; Having many wrinkles on the face; type of 1 or 5 of wrinkle scoring; having a mental disorder; having an obsessed disorder; having any skin disorder; having any major disorder; having a systemic disorder; having an oral disorder;

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quantity of nasolabial fold wrinkle - Extension. Timepoint: 1- 3 - 6 Month after cell therapy. Method of measurement: Biometry with visioface & skin sonography.;Quality of nasolabial fold wrinkle - deep. Timepoint: 1 - 3 - 6 Mounth after intervention. Method of measurement: Visio face & skin sono.

Secondary

MeasureTime frame
Color. Timepoint: 1 - 3 - 6 Month after cell therapy. Method of measurement: Biometry with colorimeter.;Elastisity. Timepoint: 1 - 3 - 6 Eounth after intervention. Method of measurement: MPA 9.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammadamir Amirkhani

Skin & Stem Cell Research Center of Tehran University of Medical sciences

amirkhani@health.gov.ir+98 21 2220 1710

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026